The first step in personalized medicine?
Warfarin, sold under the brand name Coumadin and in generic forms, yesterday became the first widely used drug to include genetic testing information on its label. The information can help doctors determine how best to prescribe the drug.
“This means personalized medicine is no longer an abstract concept but has moved into the mainstream,” the Food and Drug Administration’s clinical pharmacology chief, Larry Lesko, said in disclosing the label change.
Dr. Wes is skeptical.
